J Korean Ophthalmol Soc.  2009 Feb;50(2):235-241. 10.3341/jkos.2009.50.2.235.

Longitudinal Analysis of Retinal Nerve Fiber Layer Thickness With GDx-VCC in Glaucoma Suspect

• Suh W
• Jun RM
• Choi KR

• KMID: 2212054
• DOI: http://doi.org/10.3341/jkos.2009.50.2.235

Abstract

PURPOSE: The changes of retinal nerve fiber layer thickness with GDx-VCC were analyzed to assess the use of this instrument for longitudinal follow-up of retinal nerve fiber layers.
METHODS
From July 2004 to July 2007, patients suspected of glaucoma were measured with GDx-VCC at baseline and measurements were repeated at a minimum interval of 12 months. The medical records of 150 patients were reviewed and 42 patients that showed glaucomatous visual field progression in 36 months were classified into a "progression group" and 108 patients with no visual field loss were classified into a "nonprogression group".
RESULTS
In the nonprogression group, the temporal superior-nasal-inferior-temporal (TSNIT) average and theinferior average showed statistically significant changes for the follow up periods. However, in theprogression group, there were no parameters with significant changes even though glaucomatous visual field loss was found. The visual field progressed at a rate of 0.1dB/year in the progression group but the relationship between MD, PSD and GDx-VCC parameters could not be established.
CONCLUSIONS
GDx-VCC may not be sufficient for longitudinal assessment of the RNFL, especially during the early glaucomatous visual field changes. The progression of glaucoma only with GDx-VCC should be cautiously evaluated, and confirmation with the visual field which elucidates early glaucomatous changes is necessary. Further study is needed before GDx-VCC can be recommended as the instrument for longitudinal assessment.

Keyword

GDx-VCC; Glaucoma suspect; Visual field

MeSH Terms

Follow-Up Studies
Glaucoma
Humans
Medical Records
Nerve Fibers
Retinaldehyde
Visual Fields
Retinaldehyde

Reference

References

1. Quigley HA, Addicks EM, Green WR. Optic nerve damage in human glaucomaⅢ. Quantatitative correlation of nerve fiber loss and visual field defect in, ischemic neuropathy, papilledema, and toxic neuropathy. Arch Ophthamol. 1982; 100:135–46.

2. Weinreb RN, Shakiba S, Zangwill L. Scanning laser polarimetry to measure nerve fiber layer of normal and glaucomatous eyes. Am J Ophthalmol. 1995; 119:627–36.

3. Nicolas JR, Hans GL. Diagnostic accuracy of the GDx-VCC for glaucoma. Ophthalmology. 2004; 111:1860–5.

4. Frenkel S, Slonim E, Horani A, et al. Operator learning effect and interoperator reproducibility of the scanning laser polarimeter with variable corneal compensation. Ophthalmology. 2005; 112:257–61.

5. Medeiros FA, Doshi R, Zangwill LM, et al. Long-term variability of GDx-VCC retinal nerve fiber layer thickness measurement. J. Glaucoma. 2007; 16:277–81.

6. Shields MB. Optic nerve, retina, and choroid., Glucoma suspecta. Shields MB, editor. Shields’ Textbook of glaucoma. 5th ed.Baltimore: Lippincott Wiliams & Wilkins;2005. chap. 4.

7. O'conor DJ, Caprioli J. Comparison of methods to detect glaucomatous damage. Ophthalmology. 1993; 100:1498–503.

8. Greenfield D, Knighton R, Feuer WJ, et al. Correction for corneal polarization axis improves discriminating power of scanning lasers polarimetry. Am J Ophthalmol. 2002; 134:27–33.

9. Bagga H, Greenfield DS, Feuer W, Knighton RW. Scanning laser polarimetry with variable corneal compensation and optical coherence tomography in normal andeyes. Am J Ophthalmol. 2003; 135:521–9.

10. Medeiros FA, Zangwill LM, Bowd C, et al. Comparison of scanning laser polarimetry using variable corneal compensation and retinalnerve fiber layer photography for detection of glaucoma. Arch Ophthalmol. 2004; 122:698–704.

11. Sebi M, Ume S, Greenfield DS. Scanning laser polarimetry with enhancedcorneal compensation and optical coherence tomography in normal andeyes. Invest Ophthalmol Vis Sci. 2007; 48:2099–104.

12. Funaki S, Shirakashi M, Yaoeda K, et al. Specificity and sensitivity of glaucoma detection in the Japanese population using scanning laser polarimetry. Br J Opthalmol. 2002; 86:70–4.

13. Reus NJ, Lemij HG. Scanning laser polarimetry of the retinal nerve fiber layerperimetically unaffected eyes of glaucoma patients. Ophthalmology. 2004; 111:2199–203.

14. Poinoosawmy D, Fontana L, Wu JX, et al. Variation of nerver fiber layermeasurements with age and ethnicity by scanning laser polarimetry. Br J Ophthalmol. 1997; 81:350–4.

15. Kitazawa Y, Aoki S, Suzuki M, Nishioka K. Untreated ocular hypertension: a long-term prospective study. Arch Ophthalmol. 1977; 95:1180–4.

16. Iacono P, Da Pozzo S, Fuser M, et al. Intersession reproducibility of retinal nerve fiber layer thickness measurement by GDx-VCC in healthy and glaucomatous eyes. Ophthalmology. 2006; 220:266–71.

17. Reus NJ, Lemij HG. Diagnostic accuracy of the GDx-VCC for glaucoma. Ophthalmolgy. 2004; 111:1860–5.

18. Da Pozzo S, Fuser M, Vattovani O, et al. GDx-VCC performance in discriminating normal from glaucomatous eyes with early visual field loss. Graefes Arch Clin Exp Ophthalmol. 2006; 244:689–95.

19. Cho HS, Seong MC, Kook MS. Scanning laser polarimetry using variable corneal compensation in detection of localized visual field defects. Ophthalmology. 2005; 112:1970–8.

20. Boehm MD, Nedrud C, Greenfield DS, Chen PP. Scanning laser polarimetry and of progression after optic disc hemorrhage in patients with glaucoma. Arch Ophthalmol. 2003; 121:189–94.

21. Bowd C, Zangwill LM, Weinerb RN. Association between scanning laser polarimetry measurement using variable corneal polarization compensation and visual field sensitivity in glaucomatous eyes. Arch Ophthalmol. 2003; 121:961–6.

22. Lee SY, Ha DW, Kook MS. Ability of scanning laser polarimetry (GDx) to discriminate among early glaucomatous, ocular hypertensive and normal eyes in the Korean population. Korean J Ophthalmol. 2004; 18:1–8.

23. Mohammadi K, Bowd C, Weinreb RN, et al. Retinal nerve fier layer thickness measurements with scanning laser polarimetry predict glaucomatous visual field loss. Am J Ophthalmol. 2004; 138:592–601.

24. Essock EA, Gunvant P, Zheung Y, et al. Predicting visual field loss in ocular hypertensive patients using Wavelet-Fourier analysis of GDx scanning laser polarimetry. Optom Vis Sci. 2007; 84:380–6.

25. Essock EA, Zheung Y, Gunvant P. Analysis of GDx-VCC polarimetry data by Wavelet-Fourier analysis across glaucoma stage. Invest Ophthalmol Vis Sci. 2005; 46:2838–47.